Hi Curlednoodles, it was that discussion that motivated me to put my thoughts down, figured it needed a new thread. I could probably write a few more posts just on Intel patents and research, which I probably might do soon since there is a bunch more to say on Intel and IBM. We are looking at a 7 year development history that I've been following very closely, watching it unfold.
it comes down to these very basic points. It sounds like marketing, but it's the truth:
Akida has this going for it:
1) one-shot learning2) on-chip learning3) on-chip convolution
4) it's cheap to produce5) it's entirely digital6) it's scalable7) it's IP is licensable
8) it's available now
when you are considering a potential customer having to choose between Akida or a competitor, you have to at least consider the above list and then come up with a strong enough justification for choosing against Akida.
just something to keep in mind when looking at potential competitors in the market
- Forums
- ASX - By Stock
- First mover advantage
Hi Curlednoodles, it was that discussion that motivated me to...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online